The role of PD-L1+ DCs has been investigated in cancer because of their ability to suppress T-cell function44 and it has been shown that PD-L1+ DCs acquire a regulatory profile (mregDCs) that impairs antitumor immunity45. Here, CD274 is linked to cancer.